Clinical Trial Update: Linperlisib Combined With Chidamide in Patients With PTCL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the combination of linperlisib with chidamide in patients with peripheral T-cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Linperlisib (linperlisib)

Snippet

Sponsor: Yanyan Liu | Conditions: Peripheral T-cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING